Related Experiment Video
Updated: Dec 9, 2025
09:15
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.8K
Tumor Immunotherapy Using A2A Adenosine Receptor Antagonists
Jinfeng Zhang1,2, Wenzhong Yan1, Wenwen Duan1
1iHuman Institute, ShanghaiTech University, Shanghai 201210, China.
Pharmaceuticals (Basel, Switzerland)
|September 11, 2020
Summary
A2A adenosine receptor (A2AAR) antagonists show promise for cancer immunotherapy. Recent advances and clinical data highlight their therapeutic potential in preclinical models and human trials for antitumor drug development.
Area of Science:
- Pharmacology
- Immunology
- Oncology
Background:
- The A2A adenosine receptor (A2AAR) is a key target in human physiology and disease.
- Historically, A2AAR antagonists were developed for Parkinson's disease treatment.
- Emerging roles in immuno-oncology have repositioned A2AAR antagonists as potential antitumor drugs.
Purpose of the Study:
- To review recent advancements in A2AAR antagonist development for cancer immunotherapy.
- To discuss the therapeutic potential of A2AAR antagonists in oncology.
- To analyze preclinical and clinical data for A2AAR-targeted cancer therapies.
Main Methods:
- Literature review of recent scientific publications.
- Analysis of preclinical efficacy studies.
- Evaluation of clinical trial data for A2AAR antagonists.
Main Results:
- A2AAR antagonists are actively being investigated as lead compounds for cancer drugs.
- Numerous A2AAR antagonists are in preclinical and clinical development for cancer immunotherapy.
- Evidence from animal models and human trials supports the therapeutic potential of these agents.
Conclusions:
- A2AAR antagonists represent a promising strategy for cancer immunotherapy.
- Further research and clinical evaluation are ongoing to optimize their use.
- Targeting A2AAR offers a novel approach to developing effective antitumor therapies.
Related Concept Videos
01:27Tumor Immunotherapy
1.4K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.4K
02:57Targeted Cancer Therapies
8.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.5K
01:30Cancer Vaccines
856
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
856
02:17The Tumor Microenvironment
7.4K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.4K
02:49Cancer Therapies
9.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K
02:50Combination Therapies and Personalized Medicine
5.7K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.7K